It is a paper public limited company based in Haveli, Maharashtra, India, established in 2024.
2024 | Haveli, Maharashtra, India | ActiveEmcutix Biopharmaceuticals Limited, a active public limited company, was established on 03 October 2024 in Haveli, Maharashtra, India. Engaging in paper & paper products within the paper sector, it holds CIN: U21002PN2024PLC234721. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹0.10 M.
Its leadership includes Vikas Madan Thapar (Director), Satish Ramanlal Mehta (Additional Director), Raman Pillai Raghu Kumar (Additional Director). Past directors included Sunil Rajanikant Mehta, Sanjay Rajanikant Mehta, Govindan Sathya Narayanan. Its latest AGM occurred on 28 August 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. P-1 & P-2, It-Bt, Park, Phase-Ii, M.I.D.C., Haveli, Maharashtra, 411057.
U21002PN2024PLC234721
234721
03 October 2024
₹10.00 Cr
₹0.10 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Emcutix Biopharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vikas Madan Thapar | Director | 03 Oct 2024 | Current |
| Satish Ramanlal Mehta | Additional Director | 04 Oct 2024 | Current |
| Raman Pillai Raghu Kumar | Additional Director | 19 Dec 2024 | Current |
| Samit Satish Mehta | Additional Director | 04 Oct 2024 | Current |
| Govindan Sathya Narayanan | Ceo | 15 Oct 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 19 Dec 2024 | Past |
| Pramod Abcsdd | Director | 19 Dec 2024 | Past |
| Pramod Abcsdd | Additional Director | 15 Oct 2024 | Past |
| Pramod Abcsdd | Individual Subscriber | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Emcutix Biopharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Emcutix Biopharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Emcutix Biopharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Emcutix Biopharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Emcutix Biopharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Emcutix Biopharmaceuticals Limited last Annual general meeting of members was held on 28 Aug 2025 as per latest MCA records. was recorded as a recent event.
The activity Emcutix Biopharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was completed.
Progress on Raman Pillai Raghu Kumar was appointed as a Additional Director was appointed as a Additional Director on 19 Dec 2024 & has been associated with this company since 11 months 9 days . was documented.
Govindan Sathya Narayanan was appointed as a Ceo was appointed as a Ceo on 28 Nov 2024 & has been associated with this company since 11 months 30 days . was recorded as a recent event.
Progress on Govindan Sathya Narayanan was appointed as a CEO was appointed as a CEO on 15 Oct 2024 & has been associated with this company since 1 year 1 month . was documented.
The activity Satish Ramanlal Mehta was appointed as a Additional Director was appointed as a Additional Director on 04 Oct 2024 & has been associated with this company since 1 year 1 month . was completed.
The CIN of Emcutix Biopharmaceuticals Limited is U21002PN2024PLC234721.
Emcutix Biopharmaceuticals Limited is headquartered at Plot No. P-1 & P-2, It-Bt, Park, Phase-Ii, M.I.D.C., Haveli, Maharashtra, 411057.
Emcutix Biopharmaceuticals Limited was incorporated on 03 October 2024.
The current directors of Emcutix Biopharmaceuticals Limited are
The primary industry of Emcutix Biopharmaceuticals Limited is Paper.
Emcutix Biopharmaceuticals Limited is unlisted.
The authorized capital of Emcutix Biopharmaceuticals Limited is ₹10.00 Cr, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX